Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO--(BUSINESS WIRE)--Apr. 9, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
圣地亚哥--(美国商业资讯)--2024年4月9日--领先的胰岛素输送和糖尿病技术公司Tandem Diabetes Care, Inc.（纳斯达克股票代码：TNDM）计划在2024年5月2日星期四金融市场收盘后发布其2024年第一季度业绩。公司将在美国东部时间当天下午 4:30（太平洋时间下午 1:30）举行电话会议和同步网络直播，讨论其2024年第一季度的财务和经营业绩。
A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section. To access the call by phone, please use this link (https://register.vevent.com/register/BI12c72cd6ea054b01881ba78dd494dcc0) and you will be provided with dial-in details, including a personal pin.
电话会议的网络直播将在Tandem Diabetes Care的投资者中心网站上播出，该网站位于 http://investor.tandemdiabetes.com 在 “活动和演示” 部分。要通过电话接听电话，请使用此链接 (https://register.vevent.com/register/BI12c72cd6ea054b01881ba78dd494dcc0），您将获得拨入详细信息，包括个人密码。
An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.
网络直播的档案将在活动结束后的30天内在Tandem Diabetes Care的投资者中心网站上公布，该网站位于 http://investor.tandemdiabetes.com 在 “活动和演示” 部分中。
About Tandem Diabetes Care, Inc.
关于 Tandem 糖尿病护理公司
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care是一家全球胰岛素输送和糖尿病技术公司，生产和销售先进的自动化胰岛素输送系统，可减轻糖尿病管理的负担，同时为患者、他们的亲人和医疗保健提供者创造新的可能性。该公司的泵产品组合包括Tandem Mobi系统和t: slim X2胰岛素泵，两者均采用Control-iq先进的混合闭环技术。Tandem 糖尿病护理总部位于加利福尼亚州圣地亚哥。欲了解更多信息，请访问 tandemdiabetes.com。
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
Tandem Diabetes Care、Tandem 徽标、Control-IQ、Tandem Mobi 和 t: slim X2 是 Tandem Diabetes Care, Inc. 在美国和/或其他国家的注册商标或商标。
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409009517/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
媒体联系人：
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
投资者联系人：
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
来源：Tandem Diabetes Care, Inc.